Finding out you have a thyroid nodule can be alarming — especially when it is discovered unexpectedly on an imaging study done for something else entirely. But here is the reassuring truth: the vast majority of thyroid nodules are benign, never cause symptoms, and require nothing more than periodic monitoring.

That said, some nodules do warrant further evaluation, and a small percentage turn out to be thyroid cancer. Knowing the difference — and following the right workup — is exactly what primary care is for.

At Manatee Primary Care in Bradenton, FL, we evaluate thyroid nodules, coordinate appropriate imaging and specialist referrals, and help patients understand what their findings actually mean.

The thyroid is a butterfly-shaped gland at the base of the neck that produces hormones regulating metabolism, heart rate, body temperature, and energy. A thyroid nodule is a discrete lump or growth within the thyroid gland — essentially an area where thyroid tissue has grown abnormally.

Nodules are extremely common. Studies using high-resolution ultrasound find thyroid nodules in up to 68% of the general population. The vast majority are:

• Benign colloid nodules: Simply overgrown normal thyroid tissue
• Thyroid cysts: Fluid-filled sacs, almost always benign
• Follicular adenomas: Benign tumors of thyroid tissue
• Hashimoto's thyroiditis: Autoimmune inflammation that can create a nodular appearance

Only about 5–15% of thyroid nodules are malignant (cancerous) — and even thyroid cancer, when caught early, has an excellent prognosis. The 10-year survival rate for papillary thyroid cancer (the most common type) exceeds 95%.

Most thyroid nodules cause no symptoms and are discovered in one of three ways:

1. Incidentally on imaging: A CT scan, MRI, or ultrasound done for the neck, chest, or spine picks up a nodule that was never suspected
2. Physical examination: A provider feels a lump in the neck during a routine exam
3. Symptoms: Less commonly, a large nodule causes a visible lump, difficulty swallowing, a sensation of pressure in the throat, or hoarseness

Nodules found incidentally on CT or MRI are called incidentalomas and still require appropriate follow-up — the imaging modality that found them is not designed to characterize thyroid tissue the way ultrasound is.

While most nodules are asymptomatic, certain features should prompt faster evaluation:

• Rapid growth of a neck mass
• Hoarseness or voice changes (suggesting involvement of the recurrent laryngeal nerve)
• Difficulty swallowing or breathing
• Swollen lymph nodes in the neck
• A nodule that feels hard and fixed (not movable)

These features do not confirm cancer, but they warrant expedited workup.

Ultrasound is the cornerstone of thyroid nodule evaluation. It is painless, uses no radiation, and provides detailed information about:

• Nodule size, number, and location
• Composition (solid, cystic, or mixed)
• Echogenicity (how the nodule appears relative to surrounding tissue)
• Margins (smooth vs. irregular)
• Calcifications (certain patterns are associated with higher cancer risk)
• Vascularity

Radiologists and endocrinologists use standardized reporting systems — most commonly ACR TI-RADS (Thyroid Imaging Reporting and Data System) — to classify nodules by their ultrasound features and recommend whether biopsy is needed.

TI-RADS categories range from TR1 (benign) to TR5 (highly suspicious). The category, combined with nodule size, determines whether a biopsy is recommended.

A TSH (thyroid-stimulating hormone) level is checked in all patients with thyroid nodules. If TSH is low (suggesting the thyroid is overactive), a thyroid scan (nuclear medicine study) may be ordered to determine whether the nodule is "hot" (overactive) — hot nodules are almost never cancerous and typically do not require biopsy.

Additional thyroid tests (free T4, T3, thyroid antibodies) may be ordered depending on the clinical picture.

When ultrasound features or nodule size meet biopsy criteria, a fine needle aspiration (FNA) is performed. This is an outpatient procedure in which a thin needle is inserted into the nodule (usually under ultrasound guidance) to collect cells for examination under a microscope.

FNA results are reported using the Bethesda System:

Bethesda II (benign) is the most common result and typically means the nodule can be monitored with periodic ultrasound rather than surgery.

For indeterminate results (Bethesda III or IV), molecular testing of the biopsy sample can help clarify cancer risk. Tests like Afirma Gene Sequence Classifier or ThyroSeq analyze genetic markers in the nodule cells to better predict whether surgery is needed. This has significantly reduced the number of patients who undergo surgery for ultimately benign nodules.

Surgery (thyroidectomy — removal of part or all of the thyroid) is recommended when:

• Biopsy confirms or is highly suspicious for thyroid cancer
• A nodule is very large (typically >4 cm) and causing compressive symptoms
• A "hot" nodule is causing hyperthyroidism that cannot be managed medically
• Molecular testing suggests high malignancy risk

Most thyroid cancers are treated with surgery alone. Radioactive iodine therapy is added for higher-risk cases. Thyroid hormone replacement (levothyroxine) is needed after total thyroidectomy.

An important shift in thyroid cancer management: small, low-risk papillary thyroid cancers (under 1 cm, no lymph node involvement, no aggressive features) can often be managed with active surveillance — careful monitoring with ultrasound rather than immediate surgery. This approach, well-established in Japan and increasingly adopted in the United States, avoids surgery and its risks in patients whose cancer is unlikely to progress.

Nodules confirmed as benign on biopsy, or low-suspicion nodules that do not meet biopsy criteria, are monitored with periodic ultrasound — typically every 1–2 years. If a nodule grows significantly (more than 20% in two dimensions, or more than 2 mm in two dimensions), repeat biopsy may be recommended.

Most benign nodules remain stable for years. Many shrink over time, particularly cystic nodules.

While most nodules are benign, certain factors increase the likelihood of malignancy:

• Radiation exposure: History of head or neck radiation, particularly in childhood
• Family history: First-degree relative with thyroid cancer or certain genetic syndromes (MEN2, familial adenomatous polyposis)
• Age: Nodules in children and young adults carry higher malignancy risk
• Sex: Thyroid nodules are more common in women, but malignant nodules are proportionally more common in men
• Nodule characteristics: Solid, hypoechoic, irregular margins, microcalcifications, taller-than-wide shape on ultrasound

• Do not panic: The overwhelming majority of thyroid nodules are benign. An incidental finding on imaging is not a cancer diagnosis
• Do not skip follow-up: Even benign-appearing nodules benefit from appropriate monitoring. Skipping recommended ultrasounds means missing the rare nodule that changes over time
• Do not self-diagnose based on symptoms: Thyroid nodules rarely cause symptoms. Fatigue, weight changes, and temperature sensitivity are more likely related to thyroid function (hypothyroidism or hyperthyroidism) than to the nodule itself

When a thyroid nodule is found — whether on your exam or on imaging — we will:

1. Order a thyroid ultrasound and TSH if not already done
2. Review the results and apply current guidelines (ACR TI-RADS) to determine next steps
3. Refer to endocrinology or an interventional radiologist for biopsy when indicated
4. Coordinate with surgery if needed
5. Manage your thyroid function and monitor nodule stability long-term

You should not have to navigate this alone or piece together care from multiple specialists without a primary care home base.

If you have been told you have a thyroid nodule, or if you have noticed a lump in your neck, call Manatee Primary Care at (941) 867-9362 or request an appointment online. We serve patients throughout Bradenton, Sarasota, Parrish, Anna Maria Island, Palmetto, and Ellenton.